Marcelo Nociari

Dr. Marcelo Nociari


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CPChendong Pan
Chendong Pan
KBKalpita Banerjee
Kalpita Banerjee
GLGuillermo L. Lehmann
Guillermo L. Lehmann
DADena Almeida
Dena Almeida
KHKatherine A. Hajjar
Katherine A. Hajjar
MNMarcelo Nociari
Marcelo Nociari
Significance: Retinal lipofuscin causes retinal pigment epithelium cell death in Stargardt and potentially dry–Age-Related Macular Degeneration (AMD). The current dogma is that lipofuscin’s cytotoxicity results from the light-triggered decomposition of its lipid-bisretinoids leading to apoptosis. However, antiapoptotic antioxidants or light-blocking lenses are not effective to stop degeneration in Stargardt and most AMD patients. Here, we show that lipofuscin forms aggregates in lysosomes, which trigger lysosomal membrane permeabilization and subsequent atypical necroptosis. We provide evidence that necrosulfonamide, necrostatin-7, and arimoclomol can effectively control this lethal cascade.

24 March 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MNMarcelo Nociari
Marcelo Nociari
GLGuillermo L. Lehmann
Guillermo L. Lehmann
ABAndres E. Perez Bay
Andres E. Perez Bay
RRRoxana A. Radu
Roxana A. Radu
ZJZhichun Jiang
Zhichun Jiang
EREnrique Rodriguez-Boulan
Enrique Rodriguez-Boulan
Significance: Lipofuscin accumulation in the retinal pigment epithelium (RPE) is a hallmark of aging. High lipofuscin levels in the RPE have been associated with retinal degeneration and blindness in Stargardt disease patients and animal models. Currently, there is no treatment to prevent and/or revert lipofuscin-driven retinal degenerative changes. In this study, we report that beta cyclodextrins, cyclic sugars composed of seven glucose units, can bind retinal lipofuscin, prevent its oxidation and remove it from RPE. This study opens an avenue to develop small drugs against, currently untreatable, lipofuscin-associated blinding disorders.

30 August 2017
Verified
Book Chapter
Open access
PDF file
MNMarcelo Nociari
Marcelo Nociari
SKSzilard Kiss
Szilard Kiss
EREnrique Rodriguez-Boulan
Enrique Rodriguez-Boulan
Photoreceptors undergo a constant renewal of their light sensitive outer segments (POSs). In the renewal process, 10% of the POS mass is daily phagocytized by the adjacent retinal pigment epithelium (RPE). POS contain vast amounts of 11-cis retinal and all-trans-retinal, two highly reactive vitamin A aldehydes that spontaneously dimerize into lipid bisretinoids (LBs) and accumulate into RPE lysosomes during phagocytosis. As LBs are refractory to lysosomal hydrolases and RPE cells do not divide, this accumulation is irreversible and results in the formation of lipofuscin granules. Lipofuscin accumulation is toxic for RPE cells through a variety of light-dependent and light-independent mechanisms. Beyond a threshold, RPE cells die resulting in secondary loss of overlying photoreceptors. Currently, there are no effective treatments for retinal disorders associated with genetic or age-associated LB accumulation, such as Stargardt disease and age-related macular degeneration (AMD). Thus, there is a great need for medical interventions. Here, we discuss the current understanding of lipofuscin's pathogenicity and the status of different strategies under development to promote LB elimination from RPE lysosomes.